News Snapshot:
The Pfizer-BioNTech COVID-19 vaccine has already received approval for emergency use in several countries, including the U.S., UK, and Singapore. © Reuters December 18, 2020 02:48 JST | Japan Copy Copied TOKYO (Kyodo) -- U.S. pharmaceutical giant Pfizer will request formal approval Friday by Japan of its COVID-19 vaccine for the novel coronavirus as the first supplier in the country to do so, according to sources familiar with the move. The Japanese government has already agreed with Pfizer to receive a supply of 120 million vaccine doses, enough for 60 million people, or roughly half of its population. The U.S....
